Table 1.

Association of the lead variants at 18 newly identified loci with natural log transformed plasma fibrinogen concentration (g/l)

LocusVariantPositionClosest geneeQTLNSYN variantsA1/A2FrequencyβP-values
2p25.3rs75882853 648 186COLEC11C/G0.200.00741.2 × 10−08
3p25.3rs622463439 543 642LHFPL4T/C0.170.00712.2 × 10−08
3q21.1rs1976714122 864 771PDIA5T/G0.35−0.00552.3 × 10−08
3q21.33:129228166129 228 166IFT122RPL32P3D/R0.100.0091.0 × 10−08
7p14.2rs271080436 084 529EEPD1C/T0.370.00552.9 × 10−09
7q36.17:150289652150 289 652GIMAP4GIMAP4D/R0.21−0.00739.3 × 10−11
8p23.1rs70128149 173 358LOC157273A/G0.470.00602.1 × 10−10
9q22.2rs313849392 219 260GADD45GSEMA4DT/C0.48−0.00542.5 × 10−09
10q23.31rs225064491 008 879LIPAT/C0.330.00542.2 × 10−08
10q26.13rs2420915122 840 277MIR5694WDR11A/G0.09−0.00945.2 × 10−09
11p12rs793409443 505 707TTC17G/T0.22−0.00832.5 × 10−13
12p12.112:2170393521 703 935GYS2R/D0.370.00628.4 × 10−09
12q24.12rs7310615111 865 049SH2B3SH2B3SH2B3C/G0.50−0.00691.5 × 10−13
15q15.1rs5670297742 671 308CAPN3ZFP106A/G0.130.00802.1 × 10−09
16p11.216:2884502728 845 027ATXN2LTUFMD/R0.390.00617.7 × 10−10
16q22.2rs103556072 032 730PKD1L3HPC/T0.400.00642.6 × 10−12
17q21.2rs722473740 289 364RAB5CSTAT3HSPB9A/G0.240.00616.1 × 10−09
19q13.33rs7305805250 099 422PRR12IRF3PRRG2T/C0.160.00742.0 × 10−08
LocusVariantPositionClosest geneeQTLNSYN variantsA1/A2FrequencyβP-values
2p25.3rs75882853 648 186COLEC11C/G0.200.00741.2 × 10−08
3p25.3rs622463439 543 642LHFPL4T/C0.170.00712.2 × 10−08
3q21.1rs1976714122 864 771PDIA5T/G0.35−0.00552.3 × 10−08
3q21.33:129228166129 228 166IFT122RPL32P3D/R0.100.0091.0 × 10−08
7p14.2rs271080436 084 529EEPD1C/T0.370.00552.9 × 10−09
7q36.17:150289652150 289 652GIMAP4GIMAP4D/R0.21−0.00739.3 × 10−11
8p23.1rs70128149 173 358LOC157273A/G0.470.00602.1 × 10−10
9q22.2rs313849392 219 260GADD45GSEMA4DT/C0.48−0.00542.5 × 10−09
10q23.31rs225064491 008 879LIPAT/C0.330.00542.2 × 10−08
10q26.13rs2420915122 840 277MIR5694WDR11A/G0.09−0.00945.2 × 10−09
11p12rs793409443 505 707TTC17G/T0.22−0.00832.5 × 10−13
12p12.112:2170393521 703 935GYS2R/D0.370.00628.4 × 10−09
12q24.12rs7310615111 865 049SH2B3SH2B3SH2B3C/G0.50−0.00691.5 × 10−13
15q15.1rs5670297742 671 308CAPN3ZFP106A/G0.130.00802.1 × 10−09
16p11.216:2884502728 845 027ATXN2LTUFMD/R0.390.00617.7 × 10−10
16q22.2rs103556072 032 730PKD1L3HPC/T0.400.00642.6 × 10−12
17q21.2rs722473740 289 364RAB5CSTAT3HSPB9A/G0.240.00616.1 × 10−09
19q13.33rs7305805250 099 422PRR12IRF3PRRG2T/C0.160.00742.0 × 10−08

eQTL indicates the gene with the strongest significant association between its expression levels in blood and the lead variant or its proxy. NSYN variants indicates genes containing non-synonymous variant correlated to the lead variant (R2 > 0.9). A1 indicates the coded allele. A2 indicates the other allele. Frequency is the frequency of the coded allele. β indicates the β-coefficient adjusted for age, sex, population structure and study-specific covariates, such as center or case/control status. The β-coefficient can be interpreted as the ln(g/l) change in fibrinogen per 1 unit change in the dosage of the coded allele.

Table 1.

Association of the lead variants at 18 newly identified loci with natural log transformed plasma fibrinogen concentration (g/l)

LocusVariantPositionClosest geneeQTLNSYN variantsA1/A2FrequencyβP-values
2p25.3rs75882853 648 186COLEC11C/G0.200.00741.2 × 10−08
3p25.3rs622463439 543 642LHFPL4T/C0.170.00712.2 × 10−08
3q21.1rs1976714122 864 771PDIA5T/G0.35−0.00552.3 × 10−08
3q21.33:129228166129 228 166IFT122RPL32P3D/R0.100.0091.0 × 10−08
7p14.2rs271080436 084 529EEPD1C/T0.370.00552.9 × 10−09
7q36.17:150289652150 289 652GIMAP4GIMAP4D/R0.21−0.00739.3 × 10−11
8p23.1rs70128149 173 358LOC157273A/G0.470.00602.1 × 10−10
9q22.2rs313849392 219 260GADD45GSEMA4DT/C0.48−0.00542.5 × 10−09
10q23.31rs225064491 008 879LIPAT/C0.330.00542.2 × 10−08
10q26.13rs2420915122 840 277MIR5694WDR11A/G0.09−0.00945.2 × 10−09
11p12rs793409443 505 707TTC17G/T0.22−0.00832.5 × 10−13
12p12.112:2170393521 703 935GYS2R/D0.370.00628.4 × 10−09
12q24.12rs7310615111 865 049SH2B3SH2B3SH2B3C/G0.50−0.00691.5 × 10−13
15q15.1rs5670297742 671 308CAPN3ZFP106A/G0.130.00802.1 × 10−09
16p11.216:2884502728 845 027ATXN2LTUFMD/R0.390.00617.7 × 10−10
16q22.2rs103556072 032 730PKD1L3HPC/T0.400.00642.6 × 10−12
17q21.2rs722473740 289 364RAB5CSTAT3HSPB9A/G0.240.00616.1 × 10−09
19q13.33rs7305805250 099 422PRR12IRF3PRRG2T/C0.160.00742.0 × 10−08
LocusVariantPositionClosest geneeQTLNSYN variantsA1/A2FrequencyβP-values
2p25.3rs75882853 648 186COLEC11C/G0.200.00741.2 × 10−08
3p25.3rs622463439 543 642LHFPL4T/C0.170.00712.2 × 10−08
3q21.1rs1976714122 864 771PDIA5T/G0.35−0.00552.3 × 10−08
3q21.33:129228166129 228 166IFT122RPL32P3D/R0.100.0091.0 × 10−08
7p14.2rs271080436 084 529EEPD1C/T0.370.00552.9 × 10−09
7q36.17:150289652150 289 652GIMAP4GIMAP4D/R0.21−0.00739.3 × 10−11
8p23.1rs70128149 173 358LOC157273A/G0.470.00602.1 × 10−10
9q22.2rs313849392 219 260GADD45GSEMA4DT/C0.48−0.00542.5 × 10−09
10q23.31rs225064491 008 879LIPAT/C0.330.00542.2 × 10−08
10q26.13rs2420915122 840 277MIR5694WDR11A/G0.09−0.00945.2 × 10−09
11p12rs793409443 505 707TTC17G/T0.22−0.00832.5 × 10−13
12p12.112:2170393521 703 935GYS2R/D0.370.00628.4 × 10−09
12q24.12rs7310615111 865 049SH2B3SH2B3SH2B3C/G0.50−0.00691.5 × 10−13
15q15.1rs5670297742 671 308CAPN3ZFP106A/G0.130.00802.1 × 10−09
16p11.216:2884502728 845 027ATXN2LTUFMD/R0.390.00617.7 × 10−10
16q22.2rs103556072 032 730PKD1L3HPC/T0.400.00642.6 × 10−12
17q21.2rs722473740 289 364RAB5CSTAT3HSPB9A/G0.240.00616.1 × 10−09
19q13.33rs7305805250 099 422PRR12IRF3PRRG2T/C0.160.00742.0 × 10−08

eQTL indicates the gene with the strongest significant association between its expression levels in blood and the lead variant or its proxy. NSYN variants indicates genes containing non-synonymous variant correlated to the lead variant (R2 > 0.9). A1 indicates the coded allele. A2 indicates the other allele. Frequency is the frequency of the coded allele. β indicates the β-coefficient adjusted for age, sex, population structure and study-specific covariates, such as center or case/control status. The β-coefficient can be interpreted as the ln(g/l) change in fibrinogen per 1 unit change in the dosage of the coded allele.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close